-
Vaccination numbers, dip in cases pushing markets: Shah
Monsoons are progressing well and this also augurs well for the markets going forward, says Rahul Shah of Motilal Oswal Financial Services
-
Here’s how mutual funds managed your money in May
In the month of May mutual funds increased weightage on PSU Banks, Oil & Gas, Automobiles, Capital Goods, Insurance, and Private Banks.
-
SIP AUM hits record highs of Rs 4.67 lakh crore in May
Equity AUM of domestic MFs increased 7.7% MoM to Rs 11.1 lakh crore in May 2021.
-
Brokerages believe SAIL can be a doubler post Q4 results
SAIL is the biggest beneficiary of improved pricing
-
With record crop production & stellar Q4 should you bet on India’s best proxy play to the rural economy?
M&M’s strategy revolves around tighter capital allocation, turning around loss-making subsidiaries, and focusing on core automobile and farm busines
-
Why Motilal Oswal’s Raamdeo Agrawal sees Sensex at 2,00,000 in 10 years
Value migration creates massive opportunity for sectors which see value inflow.
-
CLSA sees 61% upside in SBI post strong Q4 performance; should you invest?
Brokerages are upbeat on SBI due to strong asset quality and record low slippages. The bank also holds unutilized Covid provisions of ~Rs 6,300 crore.
-
These stocks rallied up to 37% last week; should you buy?
With a gain of 37.18%, TCI Express emerged as the top gainer in the BSE 500 index. Shares of the company jumped to Rs 1,295 on May 21 from Rs 944 on M
-
Brokerages see up to 45% upside in ZEEL post Q4 result; should you invest?
The management has set an ambitious outlook on double-digit ad revenue growth in FY22
-
Brokerages see over 30% upside in Gland Pharma; here’s why
Gland Pharma has purchased assets from a biologics company for Rs 90 crore and will be spending around Rs 180 crore additionally to develop & manufact
